EY seeks advice on why planned split failed
CVC raises largest buyout fund in history
Activist investor buys stake in Gucci owner Kering
Novartis announces share buyback, outlines planned spinoff
Berkshire Hathaway misses out on Activision upside
Pharma heavyweight Eli Lilly is set to acquire obesity drug developer Versanis for a potential total of $1.93 billion.
Carlyle and Trustar to sell part of their stake in McDonald's China
Hipgnosis investors ask the company to sell song rights and buy back shares
Berkshire pushes further into oil and gas
Regulatory crackdown on Ant Group and China's tech sector
Twitter holding company sues Twitter’s former lawyers
CAB payments shares fall on debut
